Current Worldwide Trends in Pediatric Helicobacter pylori Antimicrobial Resistance

被引:12
作者
Balas, Reka Borka [1 ]
Melit, Lorena Elena [1 ]
Marginean, Cristina Oana [1 ]
机构
[1] George Emil Palade Univ Med Pharm Sci & Technol, Dept Pediat 1, Gheorghe Marinescu St 38, Targu Mures 540136, Romania
来源
CHILDREN-BASEL | 2023年 / 10卷 / 02期
关键词
Helicobacter pylori; antimicrobial resistance; children; STANDARD TRIPLE THERAPY; SECONDARY ANTIBIOTIC-RESISTANCE; CLARITHROMYCIN RESISTANCE; HIGH PREVALENCE; LEVOFLOXACIN RESISTANCE; ISRAELI CHILDREN; BABA2; GENOTYPES; INFECTION; ADOLESCENTS; ERADICATION;
D O I
10.3390/children10020403
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Helicobacter pylori (H. pylori) has acquired several resistance mechanisms in order to escape the currently used eradication regimens such as mutations that impair the replication, recombination, and transcription of DNA; the antibiotics capability to interact with protein synthesis and ribosomal activity; the adequate redox state of bacterial cells; or the penicillin-binding proteins. The aim of this review was to identify the differences in pediatric H. pylori antimicrobial-resistance trends between continents and countries of the same continent. In Asian pediatric patients, the greatest antimicrobial resistance was found to metronidazole (>50%), probably due to its wide use for parasitic infections. Aside from the increased resistance to metronidazole, the reports from different Asian countries indicated also high resistance rates to clarithromycin, suggesting that ciprofloxacin-based eradication therapy and bismuth-based quadruple therapy might be optimal choices for the eradication of H. pylori in Asian pediatric population. The scarce evidence for America revealed that H. pylori strains display an increased resistance to clarithromycin (up to 79.6%), but not all studies agreed on this statement. Pediatric patients from Africa also presented the greatest resistance rate to metronidazole (91%), but the results in terms of amoxicillin remain contradictory. Nevertheless, the lowest resistance rates in most of the African studies were found for quinolones. Among European children, the most frequent antimicrobial resistance was also noticed for metronidazole and clarithromycin (up to 59% and 45%) but with a predominance for clarithromycin as compared to other continents. The differences in antibiotic use among continents and countries worldwide is clearly responsible for the discrepancies regarding H. pylori antimicrobial-resistance patterns, emphasizing the crucial role of global judicious antibiotic use in order to control the increasing resistance rates worldwide.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Antibiotic Resistance of Helicobacter pylori Strains Isolated From Pediatric Patients in Southwest China
    Li, Juan
    Deng, Jianjun
    Wang, Zhiling
    Li, Hong
    Wan, Chaomin
    FRONTIERS IN MICROBIOLOGY, 2021, 11
  • [32] Refractory Helicobacter pylori infection in Australia: updated multicentre antimicrobial resistance
    Schubert, Jonathon P.
    Ingram, Paul R.
    Warner, Morgyn S.
    Rayner, Christopher K.
    Roberts-Thomson, Ian C.
    Costello, Samuel P.
    Bryant, Robert V.
    INTERNAL MEDICINE JOURNAL, 2023, 53 (11) : 1972 - 1978
  • [33] Antimicrobial resistance and virulence in Helicobacter pylori: Genomic insights
    Mehrotra, Tanshi
    Devi, T. Barani
    Kumar, Shakti
    Talukdar, Daizee
    Karmakar, Sonali Porey
    Kothidar, Akansha
    Verma, Jyoti
    Kumari, Shashi
    Alexander, Sneha Mary
    Retnakumar, R. J.
    Devadas, Krishnadas
    Ray, Animesh
    Mutreja, Ankur
    Nair, G. Balakrish
    Chattopadhyay, Santanu
    Das, Bhabatosh
    GENOMICS, 2021, 113 (06) : 3951 - 3966
  • [34] Antibiotic Resistance of Helicobacter pylori in Children with Gastritis and Peptic Ulcers in Mekong Delta, Vietnam
    Le, Loan Thi Thuy
    Nguyen, Tuan Anh
    Nguyen, Nghia An
    Nguyen, Yen Thi Hai
    Nguyen, Hai Thi Be
    Nguyen, Liem Thanh
    Vi, Mai Tuyet
    Nguyen, Thang
    HEALTHCARE, 2022, 10 (06)
  • [35] Antimicrobial Resistance and Characteristics of Eradication Therapy of Helicobacter pylori in Japan: A Multi-Generational Comparison
    Okamura, Takuma
    Suga, Tomoaki
    Nagaya, Tadanobu
    Arakura, Norikazu
    Matsumoto, Takehisa
    Nakayama, Yoshiko
    Tanaka, Eiji
    HELICOBACTER, 2014, 19 (03) : 214 - 220
  • [36] Management of Helicobacter pylori infection in the pediatric age
    Galicia Poblet, Gonzalo
    Alarcon Cavero, Teresa
    Alonso Perez, Natalia
    Borrell Martinez, Belen
    Botija Arcos, Gonzalo
    Cilleruelo Pascual, Maria Luz
    Gonzalez Martin, Leticia Maria
    Hernandez Hernandez, Anselmo
    Martinez Escribano, Beatriz
    Ortola Castells, Xenia
    Rizo Pascual, Jana
    Urruzuno Telleria, Pedro
    Vegas Alvarez, Ana Maria
    ANALES DE PEDIATRIA, 2021, 95 (05):
  • [37] MONITORING OF ANTIBIOTIC RESISTANCE RATES OF HELICOBACTER PYLORI IN AUSTRIAN CHILDREN, 2002-2009
    Prechtl, Johannes
    Deutschmann, Andrea
    Savic, Tamara
    Jahnel, Joerg
    Bogiatzis, Athanasios
    Muntean, Wolfgang
    Hauer, Almuthe C.
    Hoffmann, Karl Martin
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (03) : 312 - 314
  • [38] Diagnosis and treatment of Helicobacter pylori in the pediatric population
    Cisaro, Fabio
    Pizzol, Antonio
    Pinon, Michele
    Calvo, Pier Luigi
    MINERVA PEDIATRICA, 2018, 70 (05) : 476 - 487
  • [39] Increasing antimicrobial resistance to clarithromycin and metronidazole in pediatric Helicobacter pylori infection in southern Taiwan: A comparison between two decades
    Lu, Hsiao-Han
    Lai, Fu-Ping
    Lo, Hsiao-Yu
    Sheu, Bor-Shyang
    Yang, Yao-Jong
    HELICOBACTER, 2019, 24 (05)
  • [40] Increasing metronidazole and rifampicin resistance of Helicobacter pylori isolates obtained from children and adolescents between 2002 and 2015 in southwest Germany
    Regnath, Thomas
    Raecke, Olaf
    Enninger, Axel
    Ignatius, Ralf
    HELICOBACTER, 2017, 22 (01)